{
  "cg:id": "Ex058",
  "cg:type": "Example",
  "dataId": {
    "cg:id": "CritAssess334",
    "cg:type": "CriterionAssessment",
    "wasGeneratedBy": {
      "cg:id": "Act062",
      "cg:type": "Activity",
      "activityTypeId": {
        "cg:id": "E10"
      },
      "timeStamp": "2016-09-05T09:30:59+00:00",
      "wasAssociatedWith": [
        {
          "cg:id": "Agent008",
          "cg:type": "Agent",
          "description": "MDS",
          "name": "Marina DiStefano"
        }
      ]
    },
    "criterion": {
      "cg:id": "BS3",
      "cg:type": "Criterion",
      "description": "Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing",
      "shortDescription": "Well-established functional studies do not show damaging effect",
      "defaultOutcome": "CG:S",
      "targetInterpretation": "LN:LA6675-8"
    },
    "variant": {
      "cg:id": "CanAll087",
      "cg:type": "CanonicalAllele",
      "preferredCtxAllele": "CtxAll093",
      "identifier": "http://reg.genome.network/allele/CA501231"
    },
    "condition": [
      {
        "cg:id": "-"
      }
    ],
    "outcome": "CG:MET",
    "hasSupportingEvidence": [
      {
        "cg:id": "EvLn077",
        "supportingData": [
          {
            "cg:id": "Func194",
            "cg:type": "FunctionalData",
            "result": "Unchanged from reference",
            "dataType": "CG:neuritegrowth",
            "contextualAllele": {
              "cg:id": "CtxAll093",
              "cg:type": "ContextualAllele",
              "relatedCanonicalAllele": {
                "cg:id": "CanAll087",
                "cg:type": "CanonicalAllele",
                "preferredCtxAllele": "CtxAll093",
                "identifier": "http://reg.genome.network/allele/CA501231"
              },
              "alleleName": "NM_152594.2(SPRED1): c.587C>T"
            },
            "gene": {
              "cg:id": "G045",
              "cg:type": "Gene",
              "symbol": "SPRED1"
            }
          }
        ]
      },
      {
        "cg:id": "EvLn078",
        "supportingData": [
          {
            "cg:id": "Func195",
            "cg:type": "FunctionalData",
            "result": "localized to apical membrane",
            "dataType": "CG:elk1phosvialucif",
            "contextualAllele": {
              "cg:id": "CtxAll093",
              "cg:type": "ContextualAllele",
              "relatedCanonicalAllele": {
                "cg:id": "CanAll087",
                "cg:type": "CanonicalAllele",
                "preferredCtxAllele": "CtxAll093",
                "identifier": "http://reg.genome.network/allele/CA501231"
              },
              "alleleName": "NM_152594.2(SPRED1): c.587C>T"
            },
            "gene": {
              "cg:id": "G045",
              "cg:type": "Gene",
              "symbol": "SPRED1"
            }
          }
        ]
      }
    ]
  },
  "index": 2,
  "authorId": {
    "cg:id": "Agent008",
    "cg:type": "Agent",
    "description": "MDS",
    "name": "Marina DiStefano"
  },
  "description": "Variant: NM_152594.2(SPRED1): c.587C>T (p.Thr196Ile)\n\nVariants in SPRED1 are associated with caf√© au lait macules (CALMs), axillary freckling, and macrocephaly. Research has demonstrated that the protein is phosphorylated and inhibits differentiation in neurons by inhibiting Map Kinase.  1) A construct with the variant was transfected into PC12 cells and they were treated with nerve growth factor to stimulated neurite outgrowth. The variant did not reduce or alter neurite outgrowth. 2) Elk1 phosphorylation, a downstream readout of Map kinase activation, was also measured by a luciferase assay and found to be unchanged. The PMID for this is: 19920235."
}
